The CHRNE gene gives instructions for part of the receptor that lets nerves tell skeletal muscles when to contract. This gene helps your body turn those signals into smooth, reliable movement. If the gene does not work properly, muscle activation can be weak or tiring, which may lead to congenital myasthenic syndrome with droopy eyelids, easy fatigue, trouble feeding, or breathing problems. Symptoms and severity can vary from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate what happens in the body. Some provide the directions for producing proteins, which do much of the work inside cells. Others mainly guide the timing, location, and level of activity of specific processes. Taken together, genes affect how your body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
CHRNEGene function
What if the gene works
The CHRNE gene helps build part of the acetylcholine receptor in adult skeletal muscle. This receptor receives nerve signals where nerves meet muscle, allowing muscles to contract and move normally.
Risk
What if the gene does not work
Variants in the CHRNE gene can disrupt nerve to muscle signaling, causing congenital myasthenic syndrome with weakness, droopy eyelids, and trouble feeding, breathing, or exercising. Milder and severe variants can affect when symptoms start and how limiting they are.
Treatment
What does that mean for your treatment
Many recessive loss-of-function variants in the CHRNE gene can support treatment with pyridostigmine, sometimes with 3,4-diaminopyridine. Dominant slow channel variants in the CHRNE gene are managed differently and may respond to fluoxetine or quinidine, while pyridostigmine can worsen weakness.
Conditions associated with CHRNE
Gene function
What if the gene works
In skeletal muscle, the CHRNE gene helps your body turn a nerve message into movement. It provides one part of the acetylcholine receptor, a protein on the muscle surface where a nerve meets a muscle. When this system works as expected, muscle fibers can respond smoothly to signals that tell them to tighten.
The CHRNE gene helps build the muscle receptor that detects acetylcholine, the chemical message released by motor nerves. This is a central part of what the CHRNE gene does in normal muscle signaling.
The CHRNE gene provides the epsilon part of a channel that opens briefly after the nerve signal arrives. This lets charged particles move into the muscle cell and starts the electrical change needed for contraction.
In mature skeletal muscle, the CHRNE gene helps form the adult version of the acetylcholine receptor. This supports steady communication between nerves and muscles during everyday movements like walking, lifting, and swallowing.
What is a variant?
A genetic variant is a small alteration in the DNA sequence within a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHRNE gene can alter the shape, stability, or timing of the acetylcholine receptor, the signal receiving protein on muscle cells. This is how CHRNE gene variants affect acetylcholine receptor function: some changes leave fewer working receptors on the cell surface, while others make the channel open for too short or too long. Milder variants may preserve some activity. More disruptive variants can reduce signaling more strongly and are often linked to earlier or more marked congenital myasthenic syndrome.
How variants are linked to conditions
Certain variants in the CHRNE gene cause congenital myasthenic syndrome, an inherited condition that often starts at birth or in childhood and leads to muscle weakness that worsens with activity. Variants in the CHRNE gene linked to congenital myasthenic syndrome can confirm the diagnosis, and different variants are associated with different subtypes and severity. Many people have droopy eyelids, feeding problems, delayed motor milestones, or breathing trouble, although the pattern can vary.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead represent normal human variation. For many genes, a variant associated with a condition points to a possible link, not a firm diagnosis, particularly when several genes and environmental influences play a role. In contrast, one well described variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHRNE, risk is driven mainly by inheritance: a child is most likely to have the condition if they inherit changed copies of the gene from both parents. Family history and parents who are blood relatives can raise the chance. In people already living with it, illness, fever, and some medicines can make weakness worse.
Inheritance of CHRNE variants
CHRNE-related conditions can be inherited in more than one way, so the inheritance of CHRNE gene variants depends on the specific condition and the type of variant. Many CHRNE variants linked to congenital myasthenic syndrome follow an autosomal recessive pattern, which means a child inherits one nonworking copy from each parent. Some CHRNE variants, especially those tied to slow channel congenital myasthenic syndrome, follow an autosomal dominant pattern, so a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy.
What does my CHRNE result mean for my family?
For CHRNE, what this means for relatives depends on the specific condition linked to the result. Most often, CHRNE-related muscle weakness that starts early in life runs in families in a recessive way, so parents, brothers, sisters, and future children may be carriers or, less often, also be affected. Some CHRNE changes are linked to a dominant form, where a parent or child may also carry the same change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry variants in the CHRNE gene, doctors use genetic testing for CHRNE variants, usually on a blood or saliva sample. A lab reads the DNA code in the CHRNE gene and compares it with the usual sequence to identify changes that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Consider CHRNE testing if there is a personal or family history of congenital myasthenic syndrome, a genetic condition that causes muscle weakness that often starts in infancy or childhood. Clues include droopy eyelids, trouble sucking or swallowing, tiring easily, or episodes of breathing weakness.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and the type of variant present. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may have a different level of sensitivity to the same treatment. This helps explain why one medicine can work well for one person but less well for another, even at a similar dose. These differences are common and can influence both benefit and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes shape responses to medications. It examines links between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more personalized. You can explore this topic further in the LearnHub.
Drugs influenced by the CHRNE gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general concerns about medicines or side effects are best discussed with your doctor. In people with CHRNE-related congenital myasthenic syndrome, specialists may use the exact gene change to help judge which muscle treatments are more likely to help and which may make weakness worse.